Studies in breast cancer settings showed that tumor-infiltrating γδ T cells could inhibit the maturation of CD4+ or CD8+ T cells and change their functions by arresting cell cycle in G0/G1 phase and increasing the expression of p53, P21, and P16. This evidence concerns the gene CD4 and neoplasm.